Ovarian Cancer Research Fund

Ovarian Cancer Research Fund
Name	Ovarian Cancer Research Fund
Founded	1994
Founders	Solomon Berson, Solomon Berson's family
Location	New York City, New York
Key people	Elizabeth Berson, Audrey Berson
Focus	Ovarian cancer research, biomarker discovery, early detection
Website	https://ocrf.org

Ovarian Cancer Research Fund. The Ovarian Cancer Research Fund is a prominent non-profit organization dedicated to advancing scientific understanding and improving outcomes for patients diagnosed with ovarian cancer. Founded in the mid-1990s, it has become a leading private funder of innovative research projects across the United States and internationally. The organization's mission centers on accelerating the development of more effective diagnostics and treatments through strategic grant-making, advocacy, and public awareness campaigns.

History and founding

The organization was established in 1994 by the family of pioneering medical researcher Solomon Berson, co-developer of the radioimmunoassay, following his death from the disease. His widow, Elizabeth Berson, and daughter, Audrey Berson, were instrumental in its creation, driven by a desire to transform personal tragedy into scientific progress. The founding was influenced by the broader advocacy movements of the era, including the work of the National Cancer Institute and the rising prominence of organizations like the American Cancer Society. Initial operations were based in New York City, with a focused goal of directing private funds directly to laboratory scientists.

Research initiatives and focus areas

The fund's research portfolio is strategically targeted at high-impact areas with significant unmet need. A primary focus has been the discovery and validation of biomarkers for the early detection of ovarian cancer, funding work at institutions like the University of Texas MD Anderson Cancer Center and the Dana-Farber Cancer Institute. It also prioritizes grants for understanding the biology of high-grade serous carcinoma, the most common and lethal subtype, and supports investigations into novel therapeutic approaches, including immunotherapy and PARP inhibitor resistance. Additional initiatives have explored the genetics of hereditary syndromes like those linked to the BRCA1 and BRCA2 genes.

Fundraising and events

The organization sustains its research programs through a diverse array of fundraising activities. Major annual events include the "Super Saturday" shopping benefit, historically held in Water Mill, New York, and the "Together in Teal" gala in Manhattan. These events often feature notable figures from the worlds of fashion, entertainment, and philanthropy, such as designers from Ralph Lauren and celebrities engaged in cancer advocacy. Community-driven efforts, including nationwide participation in the National Ovarian Cancer Coalition's awareness month activities, also generate significant support.

Impact and achievements

Since its inception, the fund has allocated over $100 million to support more than 300 research projects conducted at leading academic and medical centers worldwide. Its grants have contributed to foundational studies that informed the development of PARP inhibitors, a major class of targeted therapy for ovarian cancer. Researchers supported by the organization have published pivotal papers in journals like the New England Journal of Medicine and Nature. The fund's advocacy has also helped elevate the disease's profile within the National Institutes of Health and the United States Congress.

Organizational structure and leadership

The organization is governed by a Board of directors composed of scientific advisors, business leaders, and community advocates. Day-to-day operations are managed by an executive team, with leadership historically including members of the founding Berson family. Scientific direction is guided by a prestigious Medical Advisory Board featuring renowned oncologists and researchers from institutions such as the Memorial Sloan Kettering Cancer Center and the Johns Hopkins Hospital. This structure ensures rigorous peer review of grant applications and alignment with the most pressing scientific challenges.

Partnerships and collaborations

The fund actively collaborates with a wide network of institutions to amplify its impact. It is a founding partner of the Ovarian Cancer Research Alliance, formed through a merger with another leading group. Key scientific partnerships include consortia like the International Cancer Genome Consortium and collaborative projects with the Gynecologic Oncology Group. The organization also works with corporate partners in the pharmaceutical industry and biotechnology sector, such as Genentech and AstraZeneca, to facilitate translational research and clinical trial development.

Category:Medical research organizations Category:Ovarian cancer Category:Organizations based in New York City Category:Health charities in the United States